The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology (Q37209774)

19 August 2017

1 reference

title

The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology (English)

1 reference

19 August 2017

Jean-pierre Després

1

1 reference

19 August 2017

Amélie Cartier

series ordinal

2

1 reference

19 August 2017

Mélanie Côté

series ordinal

3

1 reference

19 August 2017

Benoit J Arsenault

series ordinal

4

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

40

1 reference

19 August 2017

issue

7

1 reference

19 August 2017

page(s)

514-523

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Role of insulin resistance and hyperglycemia in the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

The myth of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Is visceral obesity the cause of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

The hypertriglyceridemic waist phenotype among women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Diabetes and cardiovascular disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Intentional weight loss and mortality among overweight individuals with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Temporal trends in BMI among adults with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Treatment of obesity: need to focus on high risk abdominally obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Body mass index, waist/hip ratio, and coronary heart disease incidence in African Americans and whites. Atherosclerosis Risk in Communities Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rep

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Response of blood lipids to exercise training alone or combined with dietary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/07853890802004959

10.1080/07853890802004959

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference